Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2026 ,inter alia, to consider and approve 1. Unaudited Financial Results for the quarter ended 30.06.20262. Any other item with the permission of chair
Oxygenta Pharmaceutical Limited Press Release Jul 22 2026
Earlier from Oxygenta Pharmaceutical
- Oxygenta Pharmaceutical Limited Press Release Jul 14 2026
- Oxygenta Pharmaceutical Limited Press Release Jun 24 2026
- Oxygenta Pharmaceutical Limited Press Release May 26 2026
- Oxygenta Pharmaceutical Limited Press Release May 23 2026
